SCHEMBL8708264

SCHEMBL8708264

COc1cc(C/C=C2/SC(=S)NC2=O)cc(OC)c1OC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 6/20 0.70
CISD1 Q9NZ45 5/20 0.54
PDE3A Q14432 3/20 0.54
DYRK1A Q13627 3/20 0.51
MAOB P27338 2/20 0.51
MAOA P21397 1/20 0.51
CDC7 O00311 1/20 0.51
PLK4 O00444 1/20 0.51
DAPK3 O43293 1/20 0.51
DYRK3 O43781 1/20 0.51
PRKD3 O94806 1/20 0.51
MAP4K4 O95819 1/20 0.51
PRKCG P05129 1/20 0.51
CDK1 P06493 1/20 0.51
PIM1 P11309 1/20 0.51
RPS6KB1 P23443 1/20 0.51
AKT1 P31749 1/20 0.51
CSNK1A1 P48729 1/20 0.51
CSNK1D P48730 1/20 0.51
CLK2 P49760 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309755 1.00 PDE4B (0.70) PDE4BCISD1PDE3ADYRK1AMAOB
SCHEMBL8310172 0.82 PDE4B (1.00) PDE4BCISD1PDE3ADYRK1AMAOB
SCHEMBL15421628 0.82 PDE4B (1.00) PDE4BCISD1PDE3ADYRK1AMAOB
SCHEMBL8310174 0.82 PDE4B (1.00) PDE4BCISD1PDE3ADYRK1AMAOB
SCHEMBL27479995 0.81 PDE4B (0.54) PDE4BCISD1PDE3ADYRK1AMAOB
SCHEMBL27393480 0.81 PDE4B (0.72) PDE4BCISD1PDE3ADYRK1APIM1
SCHEMBL18102990 0.81 CISD1 (0.57) PDE4BCISD1PDE3ADYRK1AMAOB
SCHEMBL27412321 0.80 CISD1 (0.57) PDE4BCISD1PDE3ADYRK1AMAOB
SCHEMBL8173323 0.78 CSNK2A2 (0.64) PDE4BPDE3ADYRK1APIM1PIM2
SCHEMBL27390743 0.77 NAT1 (0.64) PDE4BCISD1PDE3ADYRK1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed